Home Cart Sign in  
Chemical Structure| 6493-05-6 Chemical Structure| 6493-05-6

Structure of Pentoxifylline
CAS No.: 6493-05-6

Chemical Structure| 6493-05-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pentoxifylline is a competitive nonselective phosphodiesterase inhibitor.

Synonyms: PTX; Oxpentifylline; Etazolate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pentoxifylline

CAS No. :6493-05-6
Formula : C13H18N4O3
M.W : 278.31
SMILES Code : O=C(N1CCCCC(C)=O)N(C)C2=C(N(C)C=N2)C1=O
Synonyms :
PTX; Oxpentifylline; Etazolate
MDL No. :MFCD00063379
InChI Key :BYPFEZZEUUWMEJ-UHFFFAOYSA-N
Pubchem ID :4740

Safety of Pentoxifylline

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P301+P312+P330

Isoform Comparison

Biological Activity

Description
Pentoxifylline (BL-191), an orally active agent, functions as a non-selective phosphodiesterase (PDE) inhibitor. It is known for its immune-modulating, anti-inflammatory, hemorheological, anti-fibrinolytic, and anti-proliferative properties. Pentoxifylline is utilized in research related to peripheral vascular disease, cerebrovascular disease, and other conditions that involve impaired regional microcirculation[1].[2].[3].

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary microglia 25 μM 6 h Pentoxifylline upregulated Mertk expression by activating PPAR-γ and promoted microglial phagocytosis of myelin debris. PMC9153105
PS cells 500, 250, 125, 62.5 and 31.25 µg/mL 3 days To evaluate the inhibitory effect of Pentoxifylline on Japanese encephalitis virus (JEV) replication. Results showed that Pentoxifylline could inhibit JEV replication in a dose-dependent manner with an IC50 of 50.3 µg/mL and a therapeutic index (TI) of 10. PMC7126905

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Bilateral common carotid artery stenosis (BCAS) model Intraperitoneal injection 50 mg/kg Once daily for 30 days Pentoxifylline alleviated cognitive impairment and white matter injury in the BCAS model by upregulating Mertk expression and promoting microglial phagocytosis of myelin debris. PMC9153105
Neonates Neonatal sepsis and necrotizing enterocolitis model Intravenous 5 mg/kg/h to 6 mg/kg 6 hours daily for 3 to 6 days To assess the effectiveness and safety of intravenous Pentoxifylline as an adjunct to antibiotic therapy on mortality and morbidity in neonates with suspected or confirmed sepsis and neonates with NEC. The results suggest that Pentoxifylline may decrease mortality and length of hospital stay, but the evidence is very uncertain for its effects on chronic lung disease, severe intraventricular hemorrhage, periventricular leukomalacia, NEC, and retinopathy of prematurity. PMC10282162
Wistar rats LPS-induced sepsis model Intraperitoneal injection 45 mg/kg Single dose, lasting 120 minutes To investigate the protective effect of PTX on gastric mucosal injury in a LPS-induced sepsis model, results showed that PTX restored PC production in the gastric mucosa and reduced inflammation and oxidative stress. PMC11673027
Swiss albino mice Japanese encephalitis virus (JEV) infection model Intraperitoneal injection 50, 100 and 200 mg/kg Twice daily for 12 days To evaluate the protective effect of Pentoxifylline in JEV-infected mice. Results showed that 100 and 200 mg/kg of Pentoxifylline could completely protect mice from lethal JEV infection, while 50 mg/kg of Pentoxifylline reduced mortality by 50%. PMC7126905

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02776059 Alcoholic Hepatitis Phase 2 Recruiting December 2033 United States, California ... More >> VA Loma Linda Healthcare System Recruiting Loma Linda, California, United States, 92357 Contact: Daniel C Chao, MD    909-825-7084 ext 6141    Daniel.Chao@va.gov    Principal Investigator: Daniel C Chao, MD          VA Long Beach Healthcare System Recruiting Long Beach, California, United States, 98022 Contact: Timothy Morgan, MD    562-826-5756    timothy.morgan@va.gov    Contact: Aliya Asghar, MPH    562 826 5212    Aliya.asghar@va.gov    LAC-USC Medical Center Recruiting Los Angeles, California, United States, 90089 Contact: Andrew Stolz, MD    323-442-2699    astolz@usc.edu    Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90502 Contact: John Tayek, MD    310-222-1237    jtayek@ladhs.org    Contact: Michael W Fleischman, MD    310 222-2475    wfleischman@labiomed.org    United States, New Mexico New Mexico VA Health Care System Recruiting Albuquerque, New Mexico, United States, 87108 Contact: Joseph M. Alcorn, MD    505-265-1711 ext 4801    Joseph.Alcorn@va.gov    Principal Investigator: Joseph M. Alcorn, MD Less <<
NCT00771446 Acute Hepatitis ... More >> Chronic Hepatitis Less << Phase 1 Phase 2 Completed - United States, California ... More >> Scripps Clinic La Jolla, California, United States, 92037 California Pacific Medical Center San Francisco, California, United States, 94115 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02161653 Severe Alcoholic Hepatitis Phase 4 Completed - Mexico ... More >> Hospital General de Mexico Mexico City, D.f., Mexico, 06726 Less <<
NCT00616382 Patent Ductus Arteriosus Phase 2 Unknown - Israel ... More >> Neonatal Intensive Care Unit - Shaare Zedek Medical Center Not yet recruiting Jerusalem, Israel, 91031 Principal Investigator: Cathy Hammerman, MD          Sub-Investigator: Irina Schorrs, MD          Sub-Investigator: Amiram Nir, MD Less <<
NCT02796469 - Completed - -
NCT02458079 Alcoholic Hepatitis Not Applicable Completed - India ... More >> Institute of Liver and Biliary Sciences New Delhi, Delhi, India, 110070 Less <<
NCT02485106 Severe Alcoholic Hepatitis Phase 3 Unknown - -
NCT00019058 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Maryland ... More >> Radiation Oncology Branch Bethesda, Maryland, United States, 20892 Less <<
NCT02898376 Breast Carcinoma ... More >> Fibrosis Less << Phase 3 Not yet recruiting December 2021 France ... More >> CHU de Besançon Hôpital Jean Minjoz Not yet recruiting Besançon, France, 25000 Contact: Bontemps Patrick, MD          ONCODOC Not yet recruiting Béziers, France, 34500 Contact: Levecq Jean-Marc, MD          Centre d'Oncologie et de Radiothérapie du Parc Not yet recruiting Chalon-sur-Saône, France, 71100 Contact: Schipman Benjamin, MD          Clinique du Parc de Charleville-Mézières Not yet recruiting Charleville-Mézières, France, 08000 Contact: Jonveaux Eric, MD          CLCC Jean Perrin Not yet recruiting Clermont Ferrand, France, 63000 Contact: Belliere-Calandry Aurélie, MD          Hôpitaux Civils de Colmar Not yet recruiting Colmar, France, 68000 Contact: Boutenbat Ghizlane, MD          Centre Georges-François Leclerc Not yet recruiting Dijon, France, 21079 Contact: Peignaux Karine, MD          Institut Daniel Hollard Not yet recruiting Grenoble, France, 38000 Contact: Claeys Marie-Virginie, MD          CHU de Grenoble, Hôpital A.Michallon Not yet recruiting La Tronche, France, 38700 Contact: Gabelle - Flandin Isabelle, MD          CHR Metz-Thionville Hôpital de Mercy Not yet recruiting Metz, France Contact: Quetin Philippe, MD          CH de Belfort-Montbéliard Site du Mittan Not yet recruiting Montbéliard, France, 25200 Contact: Boulbair Fatiha, MD          CH de Mulhouse Not yet recruiting Mulhouse, France, 68100 Contact: Grandgirard Alain, MD          Centre d'Oncologie de Gentilly Not yet recruiting Nancy, France, 54100 Contact: Marquis Isabelle, MD          CHU de Poitiers Not yet recruiting Poitiers, France, 86000 Contact: El Hajj Labib, MD          Institut Jean Godinot de Reims Not yet recruiting Reims, France, 51100 Contact: Guilbert Philippe, MD          CLCC Saint Etienne Not yet recruiting Saint-Priest en Jarez, France, 42270 Contact: Magné Nicolas, MD          Centre Paul Strauss Not yet recruiting Strasbourg, France, 67000 Contact: Salze Pierre, MD          Clinique de l'Orangerie Not yet recruiting Strasbourg, France, 67000 Contact: Karst Anne, MD          Institut Universitaire du Cancer Not yet recruiting Toulouse, France, 31000 Contact: Massabeau Carole, MD          CH de Troyes Not yet recruiting Troyes, France, 10000 Contact: Beaumont Claudine, MD          Institut de Cancérologie de Lorraine Not yet recruiting Vandoeuvre-les-Nancy, France, 54519 Contact: VOGIN Guillaume, MD       g.vogin@nancy.unicancer.fr Less <<
NCT01245257 - Completed - Denmark ... More >> Department of Medicine V, Aarhus University Hospital Aarhus, Denmark, 8000 Less <<
NCT02687841 Acute Kidney Injury Phase 3 Unknown December 2017 Taiwan ... More >> National Taiwan University Hospital Yun-Lin Branch Recruiting Douliou, Taiwan, 640 Contact: Tao-Min Huang    0972655730    taominhuang@gmail.com Less <<
NCT01263925 - Completed - -
NCT00022204 Breast Cancer ... More >> Lymphedema Less << Phase 2 Completed - United Kingdom ... More >> Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Less <<
NCT01263925 Stage II Peripheral Arterial O... More >>cclusive Disease Intermittent Claudication Fontaine Stage II PAOD Less << Phase 3 Completed - Germany ... More >> Aachen, Germany Bad Säckingen, Germany Berlin, Germany Bottrop, Germany Dortmund, Germany Dresden, Germany Düsseldorf, Germany Essen-Steele, Germany Essen, Germany Freiburg, Germany Gaggenau, Germany Görlitz, Germany Hamburg, Germany Hannover, Germany Hattingen, Germany Heidelberg, Germany Homburg, Germany Jena, Germany Karlsbad-Lang Ensteinbach, Germany Kassel, Germany Krefeld, Germany Köln, Germany Leipzig, Germany Lüneburg, Germany Mannheim-Lindenhof, Germany Mannheim, Germany Mönchengladbach, Germany München, Germany Neuss, Germany Nürnberg, Germany Osnabrück, Germany Papenburg, Germany Regensburg, Germany Seesen, Germany Warendorf, Germany Wuppertal, Germany Less <<
NCT00315679 Recurrent Aphthous Stomatitis Not Applicable Completed - United Kingdom ... More >> University Dental Hospital of Manchester Manchester, United Kingdom, M15 6FH Less <<
NCT01455337 Alcoholic Hepatitis Phase 3 Unknown December 2011 -
NCT03406169 Erectile Dysfunction ... More >> Prostate Cancer Less << Phase 3 Recruiting March 2022 United States, Texas ... More >> Brooke Army Medical Center Recruiting San Antonio, Texas, United States, 78234 Contact: Ileana King-Letzkus    210-916-2000    ileana.e.king-letzkus.civ@mail.mil Less <<
NCT02051075 Infertility Phase 4 Withdrawn(failure to recruit) - Israel ... More >> Rambam medical Center Haifa, Israel, 31096 Less <<
NCT01625845 Major Depressive Disorder ... More >> Depression Depressive Symptoms Cardiovascular Disease (CVD) Coronary Artery Disease (CAD) Heart Disease Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University-Purdue University Indianapolis (IUPUI) Indianapolis, Indiana, United States, 46202 Less <<
NCT00561093 Hypoalbuminemia ... More >> Protein-energy Malnutrition Inflammation Oxidative Stress Chronic Kidney Disease (CKD) Hemodialysis Less << Phase 3 Completed - United States, California ... More >> DaVita Nutrition Services Irvine, California, United States, 92618 Los Angeles Biomedical Research Institute (LABioMed) at Harbor-UCLA Torrance, California, United States, 90502 Less <<
NCT00154661 Primary Glomerulonephritis Not Applicable Completed - Taiwan ... More >> Yung-Ming Chen Taipei, Taiwan, 100 Less <<
NCT01625845 - Completed - -
NCT02008214 Hepacivirus H... More >>IV Infections Less << Phase 4 Unknown March 2016 Mexico ... More >> Hospital Civil de Guadalajara Not yet recruiting Guadalajara, Jalisco, Mexico, 44280 Contact: Mara Llamas-Covarrubias, BSc, PhD    +52 33 36147586    mara.covarrubias@gmail.com    Principal Investigator: Jaime Andrade-Villanueva, MD, MSc          Sub-Investigator: Luz A Gonzalez-Hernandez, MD, PhD          Sub-Investigator: Mara A Llamas-Covarrubias, BSc, PhD Less <<
NCT00001877 Pulmonary Sarcoidosis PHASE2 COMPLETED 2025-05-04 National Heart, Lung and Blood... More >> Institute (NHLBI), Bethesda, Maryland, 20892, United States Less <<
NCT03342950 Neuralgia Peripheral Phase 2 Not yet recruiting January 2019 -
NCT01291433 Radiation Induced Brachial Ple... More >>xopathy Less << Phase 3 Completed - France ... More >> Groupe Hospitalier Pitié-Salpêtrière Paris, France Hôpital Saint-Louis Paris, France Less <<
NCT01214226 Alcoholic Hepatitis ... More >> Alcoholic Liver Disease Less << Phase 3 Completed - Belgium ... More >> University hospital Brussel, Belgium, 1070 France University hospital Angers, France, 49933 Hôpital Jean Verdier (AH-HP) Bondy, France, 93143 University hospital Bordeaux, France, 33000 Centre hospitalier Béthune, France, 62408 University hospital Caen, France, 14000 Hospital Antoine Béclère (Assistance Publique des Hôpiaux de Paris) Clamart, France, 92141 Hôpital Beaujon (AH-HP) Clichy, France, 92118 Centre Hospitalier Creil, France, 60100 Hôpital Henri Mondor (AP-HP) Créteil, France, 94000 Centre hospitalier Dunkerque, France, 59240 Centre Hospitalier Lens, France, 62300 University hospital Lille, France, 59037 Centre hospitalier Sambre en avesnois Maubeuge, France, 59600 University hospital Montpellier, France, 34295 University hospital Nantes, France, 45000 University hospital Nice, France, 06202 Hôpital Saint Antoine (AP-HP) Paris, France, 75012 Hôpital de la Pitié-Salpétrière (AP-HP) Paris, France, 75013 Hôpital Cochin (AH-HP) Paris, France, 75014 University hospital Poitiers, France, 49000 University hospital Rennes, France, 35033 Centre Hospitalier Victor Provo Roubaix, France, 59100 University Hospital Strasbourg, France, 67100 Centre Hospitalier Tourcoing, France, 59208 Centre Hospitalier Valenciennes, France, 59300 University hospital, Nancy Vandoeuvre les nancy, France, 54511 Hôpital Paul Brousse (AH-HP) Villejuif, France, 94000 Less <<
NCT00188669 Breast Neoplasms Phase 2 Terminated(date August 2006. N... More >>o annual renewal) Less << - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00796822 HIV Cardiovas... More >>cular Diseases Atherosclerosis Less << Phase 2 Completed - United States, Indiana ... More >> Indiana Clinical Research Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00133393 Plasmodium Falciparum Malaria PHASE2 TERMINATED 2025-07-05 KEMRI Centre for Geographic Me... More >>dicine Research, Kilifi, Kenya Less <<
NCT00001437 Fibrosis Radi... More >>ation Injuries Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00632697 Endometriosis-Associated Infer... More >>tility Less << Phase 3 Completed - Spain ... More >> Hospital Clinic Barcelona, Spain, 08036 Less <<
NCT00000646 HIV Infections PHASE1 COMPLETED 1993-03-01 Beth Israel Deaconess - East C... More >>ampus A0102 CRS, Boston, Massachusetts, 02215, United States|Case CRS, Cleveland, Ohio, United States Less <<
NCT00002091 HIV Infections COMPLETED - CRI of New England, Brookline,... More >> Massachusetts, 02445, United States Less <<
NCT00188552 Wounds and Injuries Phase 2 Terminated(May 2007 No annual ... More >>renewal) Less << - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00796822 - Completed - -
NCT01893450 Graves Ophthalmopathy Not Applicable Terminated(Efficacy demonstrat... More >>ed on a preliminary analysis) Less << - Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico City, Distrito Federal, Mexico, 14000 Less <<
NCT00590161 Nonalcoholic Steatohepatitis Phase 2 Completed - United States, Ohio ... More >> Louis Stokes VA Medical Center Cleveland, Ohio, United States, 44106 Metrohealth Medical Center Cleveland, Ohio, United States, 44109 Cleveland Clinic Cleveland, Ohio, United States, 44195 Less <<
NCT00590161 - Completed - -
NCT02231333 Non-alcoholic Steatohepatitis Not Applicable Unknown June 2016 India ... More >> Institute of Liver & Biliary Sciences Recruiting New Delhi, Delhi, India, 110070 Contact: Dr Devraj K, MD    011-46300000    drdevurgowda@gmail.com Less <<
NCT01149304 Colorectal Cancer ... More >> Liver Metastases Irradiation Damage Radiation Induced Liver Disease Less << Phase 2 Completed - Germany ... More >> Clinic for Radiology and Nuclear Medicine Magdeburg, Sachsen-Anhalt, Germany, 39120 Less <<
NCT02368457 Osteoradionecrosis Phase 4 Completed - Spain ... More >> Vall d'Hebrón Hospital Barcelona, Spain, 08035 Less <<
NCT01384578 Non Alcoholic Steatohepatitis Phase 3 Withdrawn(Lack of funds) November 2013 India ... More >> Institute of liver and Biliary Sciences New Delhi, Delhi, India, 110070 Less <<
NCT00285298 Kidney Failure, Chronic Phase 3 Completed - -
NCT00864916 HIV Vascular ... More >>Diseases Cardiovascular Diseases Atherosclerosis HIV Infections Less << Phase 2 Completed - United States, Indiana ... More >> Infectious Diseases Research Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00271336 Necrotizing Enterocolitis PHASE2 UNKNOWN 2025-03-10 Shaare Zedek Medical Center, J... More >>erusalem, 91031, Israel Less <<
NCT01676597 Hepatopulmonary Syndrome Not Applicable Unknown September 2014 India ... More >> Institute of Liver and Biliary Sciences Recruiting New Delhi, Delhi, India, 110070 Contact: Dr Naveen , MD    011-46300000    naveenilbsdelhi@gmail.com    Contact: Dr Ankit Bhardwaj    011-46300000 ext 1032    bhardwaj.ankit3@gmail.com Less <<
NCT02368457 - Completed - -
NCT00663949 Diabetic Nephropathy Phase 2 Phase 3 Completed - Iran, Islamic Republic of ... More >> Shiraz University of Medical Sciences ,Nemazee and Faghihi Hospital Shiraz, Fars, Iran, Islamic Republic of, 0098 Less <<
NCT01809132 Acute Alcoholic Hepatitis Phase 2 Phase 3 Completed - United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40202 United States, Massachusetts University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390-9030 Less <<
NCT00102453 Muscular Dystrophy, Duchenne PHASE1|PHASE2 COMPLETED 2025-05-07 Children's National Medical Ce... More >>nter, Washington, District of Columbia, 20010, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University at St. Louis, St. Louis, Missouri, 63110, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|Texas Scottish Rite Hospital, Dallas, Texas, United States Less <<
NCT02123576 Hepatorenal Syndrome Not Applicable Terminated(Poor enrollment of ... More >>study population) Less << December 31, 2017 United States, Virginia ... More >> University of Virginia Health System Charlottesville, Virginia, United States, 22908 Less <<
NCT00583700 Fibrosis Phase 2 Completed - United States, Iowa ... More >> The University of Iowa Hospitals & Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT00583700 - Completed - -
NCT00864916 - Completed - -
NCT00155246 Chronic Kidney Disease Phase 4 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00162552 Cirrhosis Liv... More >>er Failure Less << Phase 3 Completed - France ... More >> Hôpital Beaujon Clichy, France, 92110 Less <<
NCT01102218 End Stage Renal Disease Phase 2 Terminated(Lack of statistical... More >> difference between both arms of the trial.) Less << - United States, Illinois ... More >> Fresenius Medical Care North America Chicago, Illinois, United States, 60616 United States, Michigan Fresenius Medical Care North America Kalamazoo, Michigan, United States, 49007 United States, Mississippi Fresenius Medical Care North America Brookhaven, Mississippi, United States, 39601 Fresenius Medical Care North America Tupelo, Mississippi, United States, 38801 United States, Missouri Fresenius Medical Care North America St. Ann, Missouri, United States, 63074 Fresenius Medical Care North America St. Peters, Missouri, United States, 63376 United States, Nevada Fresenius Medical Care North America Las Vegas, Nevada, United States, 89120 United States, Tennessee Fresenius Medical Care North America Columbia, Tennessee, United States, 38478 United States, Texas Fresenius Medical Care North America Irving, Texas, United States, 75039 Fresenius Medical Care North America Tyler, Texas, United States, 75701 Less <<
NCT01082003 Capsular Contractures Not Applicable Unknown June 2014 United States, Oregon ... More >> Legacy Good Samaritan Medical Center Portland, Oregon, United States, 97210 Less <<
NCT01102218 - Terminated(Lack of statistical... More >> difference between both arms of the trial.) Less << - -
NCT02230800 Long-term Adverse Effects of R... More >>adiotherapy for Pelvic Cancer Less << Phase 2 Active, not recruiting September 30, 2019 United Kingdom ... More >> The Royal Marsden NHS Foundation Trust London, United Kingdom, SW3 6JJ Less <<
NCT01508221 Brain Metastasis Phase 2 Unknown June 2017 United States, Ohio ... More >> University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45219 Contact: UC Cancer Institute    513-584-7698       Principal Investigator: Ronald Warnick, MD Less <<
NCT02397486 Head and Neck Neoplasms Phase 2 Completed - Egypt ... More >> Ain Shams University Hospitals Cairo, Egypt Less <<
NCT00660868 - Completed - Germany ... More >> Zentrum für Riechen und Schmecken, Universitäts- HNO- Klinik Dresden Dresden, Germany, 01307 Less <<
NCT00205049 Hepatitis, Alcoholic Phase 1 Terminated(lack of funding) - -
NCT00205049 - Terminated(lack of funding) - -
NCT03723291 Head and Neck Fibrosis Phase 1 Not yet recruiting October 31, 2021 -
NCT00593658 Hepatopulmonary Syndrome Phase 1 Terminated(Poor tolerability o... More >>f drug and side effects) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT01006499 Sepsis of the Newborn Phase 4 Unknown December 2010 Turkey ... More >> Zekai Tahir Burak Ankara, Turkey, 06120 Less <<
NCT03040778 Medication-related Osteonecros... More >>is of the Jaw Bisphosphonate-related Osteonecrosis of the Jaw Avascular Necrosis Less << Phase 3 Recruiting January 2020 United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35242 Contact: Anthony Morlandt, DDS, MD    205-934-3435    Morlandt@uab.edu    United States, Michigan University of Michigan Not yet recruiting Ann Arbor, Michigan, United States, 48109-0018 Contact: Brent Ward, DDS, MD    734-763-5963    bward@umich.edu    United States, New York New York Center for Orthognathic and Maxillofacial Surgery Not yet recruiting Lake Success, New York, United States, 11042 Contact: Salvatore Ruggiero, DMD, MD    516-775-1818    drruggiero@nycoms.com    United States, Washington University of Washington Recruiting Seattle, Washington, United States, 98195 Contact: Jasjit Dillon, DDS, MBBS    206-543-7722    dillonj5@uw.edu Less <<
NCT01381055 Cutaneous Leishmaniasis Phase 2 Phase 3 Completed - Brazil ... More >> Posto de Saúde de Corte de Pedra Corte de Pedra, Tancredo Neves/Bahia, Brazil, 40000 Less <<
NCT01464242 Cutaneous Leishmaniasis Phase 2 Phase 3 Completed - Colombia ... More >> Corporación Centro Internacional de entrenamiento e Investigaciónes Médicas Cali, Valle, Colombia, 5930 Less <<
NCT02530697 Leishmaniasis Phase 2 Recruiting June 2019 Brazil ... More >> Hospital Universitário de Brasília Recruiting Brasília, DF, Brazil, 70.840-901 Contact: Sofia S Martins, MD    +556120285415    sofiasalesm@gmail.com Less <<
NCT00681733 Metabolic Parameters and Liver... More >> Histology Less << Not Applicable Unknown December 2008 India ... More >> Dr. Barjesh Chander Sharma Recruiting New Delhi, India, 110001 Contact: Barjesh Ch Sharma, MD, DM    91-011-2323-4242 ext 5203    drbcsharma@hotmail.com    Principal Investigator: Barjesh Ch Sharma, MD, DM Less <<
NCT01269827 Inflammation ... More >>End-stage Renal Disease Hemodialysis Less << Phase 4 Completed - Mexico ... More >> Hospital de Especialidades, CMNO, IMSS Guadalajara, Jalisco, Mexico, 44320 Less <<
NCT00770328 Obesity Phase 4 Completed - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00243789 Muscular Dystrophy, Duchenne PHASE1|PHASE2 COMPLETED 2025-01-08 Children's National Medical Ce... More >>nter, Washington, District of Columbia, 20010, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University, St. Louis, St. Louis, Missouri, 63110, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|University of Tennessee, Memphis, Tennessee, 38104, United States|Hospital Frances, Buenos Aires, 1434, Argentina|Children's Hospital, Melbourne, Victoria, 3052, Australia|Alberta Children's Hospital, Calgary, Alberta, T2T 5C7, Canada|University of Alberta, Edmonton, Alberta, T6G 2J3, Canada|Hadassah Hospital, Mt. Scopus, Jerusalem, 91240, Israel|IRCCS C Mondino Foundation, Pavia, 27100, Italy Less <<
NCT00770328 - Completed - -
NCT00354198 Glomerulonephritis Phase 3 Terminated(short of participan... More >>ts) Less << - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT03476564 Infertility, Female Early Phase 1 Not yet recruiting September 1, 2018 Egypt ... More >> El Galaa Teaching hosptial Recruiting Cairo, Ghamra, Egypt Less <<
NCT01249092 Primary Biliary Cirrhosis PHASE2 COMPLETED 2025-03-13 Cleveland Clinic, Cleveland, O... More >>hio, 44195, United States Less <<
NCT01822405 Fibrosis Phase 2 Unknown July 2013 Spain ... More >> Hospital Universitario de Canarias Recruiting La Laguna, S/C de Tenerife, Spain, 38320 Contact: Claudio Otón, MD       coton@ull.es    Principal Investigator: Claudio Otón, MD Less <<
NCT01472263 HTLV-1 Tropic... More >>al Spastic Paraparesis Immune System Diseases Physical Disability Pentoxifylline Less << Phase 3 Completed - Brazil ... More >> Hospital Universitário Professor Edgard Santos Salvador, Bahia, Brazil, 40110 Less <<
NCT00354731 Nephrotic Syndrome Phase 3 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT03554447 Major Depressive Disorder Not Applicable Active, not recruiting December 1, 2018 -
NCT01292005 Acute Pancreatitis Early Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01377285 Chronic Renal Failure Phase 4 Unknown December 2018 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Tun-Jun Tsai, M.D.; PhD    00886-2-23123456 ext 63953    tjtsai@ntuh.gov.tw    Contact: Yung-Ming Chen, M.D.    00886-2-23123456 ext 65993    chenym@ntuh.gov.tw    Principal Investigator: Tun-Jun Tsai, M.D.; PhD Less <<
NCT01871454 Non-small Cell Lung Cancers Phase 2 Recruiting December 2018 United States, Kentucky ... More >> James Graham Brown Cancer Center, U of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Teresa L Roberts, RN    502-333-6934    teresa.roberts@louisville.edu Less <<
NCT01249092 Primary Biliary Cirrhosis PHASE2 COMPLETED 2025-03-13 Cleveland Clinic, Cleveland, O... More >>hio, 44195, United States Less <<
NCT01144091 Contrast Induced Nephropathy ... More >> Diabetes Mellitus Less << Not Applicable Withdrawn December 2013 -
NCT01292005 - Completed - -
NCT02951299 Pentoxifylline ... More >> Acute Kidney Injury Less << Phase 2 Phase 3 Unknown August 31, 2017 -
NCT00267670 - Completed - -
NCT03625648 Diabetic Kidney Disease Phase 4 Not yet recruiting July 8, 2030 United States, Illinois ... More >> Edward Hines Jr. VA Hospital, Hines, IL Not yet recruiting Hines, Illinois, United States, 60141-5000 Contact: David J Leehey    708-202-8387 ext 22781    David.Leehey@va.gov    Study Chair: David J Leehey Less <<
NCT02283710 Fatty Liver Phase 2 Completed - Iran, Islamic Republic of ... More >> Gastroenterology clinic, Sina Hospital Tehran, Iran, Islamic Republic of Less <<
NCT00267670 Nonalcoholic Steatohepatitis ... More >> Liver Diseases Less << Phase 2 Phase 3 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT01542268 Irritable Bowel Syndrome Phase 4 Unknown January 2013 Spain ... More >> Complejo Hospitalario Universitario de Canarias Not yet recruiting La Laguna, S/c Tenerife, Spain, 38320 Contact: LAURA RAMOS, MD    +34 922675557    laura7ramos@gmial.com    Contact: ANA ALDEA, MD    +34922678115    a.aldea@gmail.com    Principal Investigator: LAURA RAMOS, MD Less <<
NCT02487225 Acute Pancreatitis (AP) ... More >> Gallstone Pancreatitis Alcoholic Pancreatitis Post-ERCP/Post-procedural Pancreatitis Trauma Acute Pancreatitis Hypertriglyceridemia Acute Pancreatitis Idiopathic (Unknown) Acute Pancreatitis Medication Induced Acute Pancreatitis Cancer Acute Pancreatitis Miscellaneous (i.e. Acute on Chronic Pancreatitis) Less << Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01469624 Nephropathy UNKNOWN 2025-06-12 University Hospitals, Shiraz, ... More >>Fars, Iran, Islamic Republic of Less <<
NCT02451774 Acute Lymphoblastic Leukemia Phase 2 Phase 3 Recruiting December 2020 Mexico ... More >> Hospital Civil de Guadalajara "Dr. Juan I. Menchaca" Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Ramon O Gonzalez Ramella, PhD    5213331719826    glezramella@hotmail.com    Contact: Fabiola P Medina Barajas, PhD    5213313461917    favyri@hotmail.com Less <<
NCT01382303 Type 2 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Ajou University Hospital Suwon, Korea, Republic of Less <<
NCT03006952 Diabetic Nephropathies Phase 4 Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of Less <<
NCT02953275 Crohn Disease Early Phase 1 Recruiting April 1, 2019 United States, Florida ... More >> University of Miami Crohn's and Colitis Center Recruiting Miami, Florida, United States, 33136 Contact: Diana Morillo    305-243-6405    dmorillo@med.miami.edu    Principal Investigator: Amar R Deshpande, MD Less <<
NCT02163174 Neonatal Late Onset Sepsis Phase 3 Completed - Egypt ... More >> Mansoura University Children Hospital Mansoura, Eldakahlia, Egypt, 35516 Less <<
NCT01337349 Congestive Heart Failure Not Applicable Unknown July 2014 United States, Michigan ... More >> Henry Ford Hospital Recruiting Detroit, Michigan, United States, 48202 Contact: Karthikeyan Ananthasubramaniam, MD    313-916-2721    kananth1@hfhs.org    Contact: Prasanth Lingam, MD    313-916-2721    plingam1@hfhs.org    Principal Investigator: Karthikeyan Ananthasubramaniam, MD          Sub-Investigator: Prasanth Lingam, MD Less <<
NCT01774487 Biliary Atresia PHASE2 TERMINATED 2023-02-20 Texas Children's Hospital and ... More >>Baylor College of Medicine, Houston, Texas, 77030, United States Less <<
NCT01793272 Pentoxifylline Allergy Not Applicable Completed - Egypt ... More >> Adam International Hospital Giza, Egypt, 12411 Less <<
NCT03060434 Lumbar Radiculopathy ... More >> Lumbar Disc Herniation Lumbar Disc Disease Less << Phase 4 Recruiting December 1, 2018 Lebanon ... More >> Hotel Dieu de France Hospital Recruiting Beirut, Lebanon, 16 6830 Less <<
NCT03664414 Chronic Kidney Disease stage3 ... More >>and 4 Type 2 Diabetes Mellitus Less << Phase 4 Recruiting December 31, 2021 Mexico ... More >> Cibimi - Hgz 83 Imss Recruiting Morelia, Michoacán, Mexico, 58290 Contact: Oliva Mejía - Rodríguez, PhD    01 4431853008    oliva.mejia@imss.gob.mx Less <<
NCT03731741 Anemia of Chronic Kidney Disea... More >>se Less << PHASE2 COMPLETED 2018-05-04 Tanta university hospital, Tan... More >>ta, Egypt Less <<
NCT01382303 - Completed - -
NCT03591536 Oxidative Stress ... More >> AKI Inflammation Less << Not Applicable Completed - -
NCT02992678 Pancreatitis Early Phase 1 Unknown September 2017 China, Anhui ... More >> Department of General Surgery, Anhui Provincial Hospital Affiliated with Anhui Medical University Recruiting HeFei, Anhui, China, 230001 Contact: Shao Feng, MD    8613033090788    tagsmile1985@163.com Less <<
NCT02592863 Dizziness Ver... More >>tigo Less << Not Applicable Enrolling by invitation January 2021 United States, Missouri ... More >> University of Missouri Columbia, Missouri, United States, 65212 Less <<
NCT05502952 Alopecia Areata UNKNOWN 2025-07-23 Sohag University Hospital, Soh... More >>ag, Egypt Less <<
NCT04152980 Neonatal Late Onset Sepsis PHASE3 COMPLETED 2022-12-31 Erasmus MC Sophia Children's H... More >>ospital, Rotterdam, 3000CB, Netherlands|University Hospital Poznan, Poznan, 61-701, Poland Less <<
NCT04739345 Covid19|Corona Virus Infection... More >>|Cytokine Storm Less << COMPLETED 2022-10-01 Teachers Hospital, Cairo, Plea... More >>se Select, 11314, Egypt Less <<
NCT05611268 Eisenmenger Syndrome RECRUITING 2026-09-30 Antonio Augusto Barbosa Lopes,... More >> S?o Paulo, Brazil Less <<
NCT06344390 Cognitive Impairment PHASE1|PHASE2 RECRUITING 2024-12-31 BHan, Shijiazhuang, China
NCT06562998 Chemotherapy-induced Periphera... More >>l Neuropathy Less << COMPLETED 2024-08-01 University Hospital, Banī Suwa... More >>yf, Beni-Suef, 13556, Egypt Less <<
NCT04367935 Acute Coronary Syndrome PHASE2|PHASE3 COMPLETED 2022-04-25 Ain Shams University Hospitals... More >>, Cairo, 11588, Egypt Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.59mL

0.72mL

0.36mL

17.97mL

3.59mL

1.80mL

35.93mL

7.19mL

3.59mL

References

 

Historical Records

Categories